During the last session, Applied Dna Sciences Inc (NASDAQ:APDN)’s traded shares were 3.68 million, with the beta value of the company hitting 0.49. At the
During the last session, Applied Dna Sciences Inc (NASDAQ:APDN)’s traded shares were 1.62 million, with the beta value of the company hitting 0.49. The 52-week
In the last trading session, 2.76 million shares of the Applied Dna Sciences Inc (NASDAQ:APDN) were traded, and its beta was 0.49. Most recently the
In the last trading session, 1.92 million Applied Dna Sciences Inc (NASDAQ:APDN) shares changed hands as the company’s beta touched 0.51. With the company’s per
In the last trading session, 2.56 million Applied Dna Sciences Inc (NASDAQ:APDN) shares changed hands as the company’s beta touched 0.51. With the company’s per
In last trading session, Applied Dna Sciences Inc (NASDAQ:APDN) saw 2.29 million shares changing hands with its beta currently measuring 0.51. Company’s recent per share
Applied Dna Sciences Inc (NASDAQ:APDN) has a beta value of 0.45 and has seen 4.83 million shares traded in the last trading session. The company,
During the last session, Applied Dna Sciences Inc (NASDAQ:APDN)’s traded shares were 5.77 million, with the beta value of the company hitting 0.36. At the
In the last trading session, 2.44 million shares of the Applied Dna Sciences Inc (NASDAQ:APDN) were traded, and its beta was 0.36. Most recently the
In today’s recent session, 1.86 million shares of the Applied Dna Sciences Inc (NASDAQ:APDN) have been traded, and its beta is 0.36. Most recently the
Marketing Sentinel delivers exclusive content, news, articles, and comprehensive coverage of events in the USA and worldwide with a commitment to reliability, objectivity, and timeliness.
© 2024, Powered by Smart TechOne
